Health · 1 sources covering this

STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership

Former FDA commissioners Rob Califf (Obama and Biden administrations), Scott Gottlieb, and Ned Sharpless (both from the first Trump administration) criticized the officials who ran the agency during a massive…

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership
Former FDA commissioners Rob Califf (Obama and Biden administrations), Scott Gottlieb, and Ned Sharpless (both from the first Trump administration) criticized the officials who ran the agency during a massive…
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/f9c0d288b85e367c89e0287e200770e783816da7"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership"></iframe>

STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership

How 1 sources are covering this

STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership

More from Health

STAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer

After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward

STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more

STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Former FDA commissioners Califf, Gottlieb, Sharpless lay into current HHS leadership

More from Health

STAT+: Verastem&#8217;s KRAS inhibitor shows promise in pancreatic cancer

After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward

STAT+: Pharmalittle: We&#8217;re reading about former FDA head calling DOGE a &#8216;disaster,&#8217; an AstraZeneca AI deal, and more

STAT+: &#8216;AI sandboxes&#8217; are all the rage. Advocates scramble to control their future

Reader

Trust & legal

Across the network

STAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer

STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more

STAT+: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future